Genomic Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

The global market for Genomic Medicine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Genomic Medicine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Genomic Medicine by region & country, by Type, and by Application.

The Genomic Medicine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomic Medicine.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Genomic Medicine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Genomic Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Genomic Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Genomic Medicine Product Introduction
    1.2 Global Genomic Medicine Market Size Forecast
    1.3 Genomic Medicine Market Trends & Drivers
        1.3.1 Genomic Medicine Industry Trends
        1.3.2 Genomic Medicine Market Drivers & Opportunity
        1.3.3 Genomic Medicine Market Challenges
        1.3.4 Genomic Medicine Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Genomic Medicine Players Revenue Ranking (2023)
    2.2 Global Genomic Medicine Revenue by Company (2019-2024)
    2.3 Key Companies Genomic Medicine Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Genomic Medicine Product Offered
    2.5 Key Companies Time to Begin Mass Production of Genomic Medicine
    2.6 Genomic Medicine Market Competitive Analysis
        2.6.1 Genomic Medicine Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Genomic Medicine Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Medicine as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Oncology
        3.1.2 Cardiology
        3.1.3 Pediatrics
        3.1.4 Endocrinology
        3.1.5 Respiratory Medicine
        3.1.6 Other
    3.2 Global Genomic Medicine Sales Value by Type
        3.2.1 Global Genomic Medicine Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Genomic Medicine Sales Value, by Type (2019-2030)
        3.2.3 Global Genomic Medicine Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Clinics
        4.1.3 Academic Institutions
        4.1.4 Research Institutions
    4.2 Global Genomic Medicine Sales Value by Application
        4.2.1 Global Genomic Medicine Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Genomic Medicine Sales Value, by Application (2019-2030)
        4.2.3 Global Genomic Medicine Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Genomic Medicine Sales Value by Region
        5.1.1 Global Genomic Medicine Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Genomic Medicine Sales Value by Region (2019-2024)
        5.1.3 Global Genomic Medicine Sales Value by Region (2025-2030)
        5.1.4 Global Genomic Medicine Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Genomic Medicine Sales Value, 2019-2030
        5.2.2 North America Genomic Medicine Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Genomic Medicine Sales Value, 2019-2030
        5.3.2 Europe Genomic Medicine Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Genomic Medicine Sales Value, 2019-2030
        5.4.2 Asia Pacific Genomic Medicine Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Genomic Medicine Sales Value, 2019-2030
        5.5.2 South America Genomic Medicine Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Genomic Medicine Sales Value, 2019-2030
        5.6.2 Middle East & Africa Genomic Medicine Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Genomic Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Genomic Medicine Sales Value
    6.3 United States
        6.3.1 United States Genomic Medicine Sales Value, 2019-2030
        6.3.2 United States Genomic Medicine Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Genomic Medicine Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Genomic Medicine Sales Value, 2019-2030
        6.4.2 Europe Genomic Medicine Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Genomic Medicine Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Genomic Medicine Sales Value, 2019-2030
        6.5.2 China Genomic Medicine Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Genomic Medicine Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Genomic Medicine Sales Value, 2019-2030
        6.6.2 Japan Genomic Medicine Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Genomic Medicine Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Genomic Medicine Sales Value, 2019-2030
        6.7.2 South Korea Genomic Medicine Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Genomic Medicine Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Genomic Medicine Sales Value, 2019-2030
        6.8.2 Southeast Asia Genomic Medicine Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Genomic Medicine Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Genomic Medicine Sales Value, 2019-2030
        6.9.2 India Genomic Medicine Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Genomic Medicine Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 BioMed Central
        7.1.1 BioMed Central Profile
        7.1.2 BioMed Central Main Business
        7.1.3 BioMed Central Genomic Medicine Products, Services and Solutions
        7.1.4 BioMed Central Genomic Medicine Revenue (US$ Million) & (2019-2024)
        7.1.5 BioMed Central Recent Developments
    7.2 Cleveland Clinic
        7.2.1 Cleveland Clinic Profile
        7.2.2 Cleveland Clinic Main Business
        7.2.3 Cleveland Clinic Genomic Medicine Products, Services and Solutions
        7.2.4 Cleveland Clinic Genomic Medicine Revenue (US$ Million) & (2019-2024)
        7.2.5 Cleveland Clinic Recent Developments
    7.3 MD Anderson Cancer Center
        7.3.1 MD Anderson Cancer Center Profile
        7.3.2 MD Anderson Cancer Center Main Business
        7.3.3 MD Anderson Cancer Center Genomic Medicine Products, Services and Solutions
        7.3.4 MD Anderson Cancer Center Genomic Medicine Revenue (US$ Million) & (2019-2024)
        7.3.5 Manchester Centre for Genomic Medicine Recent Developments
    7.4 Manchester Centre for Genomic Medicine
        7.4.1 Manchester Centre for Genomic Medicine Profile
        7.4.2 Manchester Centre for Genomic Medicine Main Business
        7.4.3 Manchester Centre for Genomic Medicine Genomic Medicine Products, Services and Solutions
        7.4.4 Manchester Centre for Genomic Medicine Genomic Medicine Revenue (US$ Million) & (2019-2024)
        7.4.5 Manchester Centre for Genomic Medicine Recent Developments
    7.5 Center for Genomic Medicine
        7.5.1 Center for Genomic Medicine Profile
        7.5.2 Center for Genomic Medicine Main Business
        7.5.3 Center for Genomic Medicine Genomic Medicine Products, Services and Solutions
        7.5.4 Center for Genomic Medicine Genomic Medicine Revenue (US$ Million) & (2019-2024)
        7.5.5 Center for Genomic Medicine Recent Developments

 8 Industry Chain Analysis
    8.1 Genomic Medicine Industrial Chain
    8.2 Genomic Medicine Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Genomic Medicine Sales Model
        8.5.2 Sales Channel
        8.5.3 Genomic Medicine Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Genomic Medicine Market Trends
    Table 2. Genomic Medicine Market Drivers & Opportunity
    Table 3. Genomic Medicine Market Challenges
    Table 4. Genomic Medicine Market Restraints
    Table 5. Global Genomic Medicine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Genomic Medicine Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Genomic Medicine Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Genomic Medicine Product Type
    Table 9. Key Companies Time to Begin Mass Production of Genomic Medicine
    Table 10. Global Genomic Medicine Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Medicine as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Genomic Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Genomic Medicine Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Genomic Medicine Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Genomic Medicine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Genomic Medicine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Genomic Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Genomic Medicine Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Genomic Medicine Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Genomic Medicine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Genomic Medicine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Genomic Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Genomic Medicine Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Genomic Medicine Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Genomic Medicine Sales Value by Region (2019-2024) & (%)
    Table 27. Global Genomic Medicine Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Genomic Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Genomic Medicine Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Genomic Medicine Sales Value, (2025-2030) & (US$ Million)
    Table 31. BioMed Central Basic Information List
    Table 32. BioMed Central Description and Business Overview
    Table 33. BioMed Central Genomic Medicine Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Genomic Medicine Business of BioMed Central (2019-2024)
    Table 35. BioMed Central Recent Developments
    Table 36. Cleveland Clinic Basic Information List
    Table 37. Cleveland Clinic Description and Business Overview
    Table 38. Cleveland Clinic Genomic Medicine Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Genomic Medicine Business of Cleveland Clinic (2019-2024)
    Table 40. Cleveland Clinic Recent Developments
    Table 41. MD Anderson Cancer Center Basic Information List
    Table 42. MD Anderson Cancer Center Description and Business Overview
    Table 43. MD Anderson Cancer Center Genomic Medicine Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Genomic Medicine Business of MD Anderson Cancer Center (2019-2024)
    Table 45. MD Anderson Cancer Center Recent Developments
    Table 46. Manchester Centre for Genomic Medicine Basic Information List
    Table 47. Manchester Centre for Genomic Medicine Description and Business Overview
    Table 48. Manchester Centre for Genomic Medicine Genomic Medicine Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Genomic Medicine Business of Manchester Centre for Genomic Medicine (2019-2024)
    Table 50. Manchester Centre for Genomic Medicine Recent Developments
    Table 51. Center for Genomic Medicine Basic Information List
    Table 52. Center for Genomic Medicine Description and Business Overview
    Table 53. Center for Genomic Medicine Genomic Medicine Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Genomic Medicine Business of Center for Genomic Medicine (2019-2024)
    Table 55. Center for Genomic Medicine Recent Developments
    Table 56. Key Raw Materials Lists
    Table 57. Raw Materials Key Suppliers Lists
    Table 58. Genomic Medicine Downstream Customers
    Table 59. Genomic Medicine Distributors List
    Table 60. Research Programs/Design for This Report
    Table 61. Key Data Information from Secondary Sources
    Table 62. Key Data Information from Primary Sources
    Table 63. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Genomic Medicine Product Picture
    Figure 2. Global Genomic Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Genomic Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Genomic Medicine Report Years Considered
    Figure 5. Global Genomic Medicine Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Genomic Medicine Revenue in 2023
    Figure 7. Genomic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Oncology Picture
    Figure 9. Cardiology Picture
    Figure 10. Pediatrics Picture
    Figure 11. Endocrinology Picture
    Figure 12. Respiratory Medicine Picture
    Figure 13. Other Picture
    Figure 14. Global Genomic Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Genomic Medicine Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Clinics
    Figure 18. Product Picture of Academic Institutions
    Figure 19. Product Picture of Research Institutions
    Figure 20. Global Genomic Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Genomic Medicine Sales Value Market Share by Application, 2023 & 2030
    Figure 22. North America Genomic Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 23. North America Genomic Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 24. Europe Genomic Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 25. Europe Genomic Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 26. Asia Pacific Genomic Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 27. Asia Pacific Genomic Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 28. South America Genomic Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 29. South America Genomic Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 30. Middle East & Africa Genomic Medicine Sales Value (2019-2030) & (US$ Million)
    Figure 31. Middle East & Africa Genomic Medicine Sales Value by Country (%), 2023 VS 2030
    Figure 32. Key Countries/Regions Genomic Medicine Sales Value (%), (2019-2030)
    Figure 33. United States Genomic Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 34. United States Genomic Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 35. United States Genomic Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 36. Europe Genomic Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Europe Genomic Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 38. Europe Genomic Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 39. China Genomic Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 40. China Genomic Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 41. China Genomic Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 42. Japan Genomic Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Japan Genomic Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 44. Japan Genomic Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 45. South Korea Genomic Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 46. South Korea Genomic Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 47. South Korea Genomic Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 48. Southeast Asia Genomic Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Genomic Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 50. Southeast Asia Genomic Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 51. India Genomic Medicine Sales Value, (2019-2030) & (US$ Million)
    Figure 52. India Genomic Medicine Sales Value by Type (%), 2023 VS 2030
    Figure 53. India Genomic Medicine Sales Value by Application (%), 2023 VS 2030
    Figure 54. Genomic Medicine Industrial Chain
    Figure 55. Genomic Medicine Manufacturing Cost Structure
    Figure 56. Channels of Distribution (Direct Sales, and Distribution)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation

The global market for Genomic Medicine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Genomic Medicine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Genomic Medicine by region & country, by Type, and by Application.

The Genomic Medicine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomic Medicine.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Genomic Medicine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Genomic Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Genomic Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.